The invention relates to novel uses for inhibin, inhibin alpha subunit, activin inhibin or activin antagonists and compositions comprising them in the treatment or prevention of immune dysfunction and blood clotting disorders. Methods of treatment include administration of the required agent to a host, immunization of the host with the agent or passive immunization using antibodies raised against one of these agents.
申请公布号
WO8911862(A1)
申请公布日期
1989.12.14
申请号
WO1989AU00245
申请日期
1989.05.31
申请人
BIOTECHNOLOGY AUSTRALIA PTY. LTD.;MONASH UNIVERSITY;MONASH MEDICAL CENTRE;ST. VINCENTS INSTITUTE OF MEDICAL RESEARCH
发明人
DE KRETSER, DAVID, MORRITZ;ROBERTSON, DAVID, MARK;HEDGER, MARK, PETER